Cover Image

Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs

Furio Pirozzi Farina, Antonella Pischedda
  • Furio Pirozzi Farina
    Andrological Urology Unit, AOU di Sassari, Sassari, Italy | andro@tin.it
  • Antonella Pischedda
    Andrological Urology Unit, AOU di Sassari, Sassari, Italy

Abstract

Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.

Keywords

5-alpha-reductase inhibitors (5ARIs); Sexual dysfunctions; Benign prostatic hyperplasia (BPH); Androgenetic alopecia

Full Text:

PDF
Submitted: 2016-01-12 13:55:08
Published: 2016-01-14 10:50:49
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
2799

Views:
PDF
2380

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Furio Pirozzi Farina, Antonella Pischedda

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185